ZEISS Microscopy’s New Microsite Teases Content in Interactive Display Wall at SfN Neuroscience 2022 Conference
Advertisement
Read this article for free:
or
Already have an account? Log in here »
To continue reading, please subscribe:
Monthly Digital Subscription
$1 per week for 24 weeks*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*Billed as $4.00 plus GST every four weeks. After 24 weeks, price increases to the regular rate of $19.95 plus GST every four weeks. Offer available to new and qualified returning subscribers only. Cancel any time.
Monthly Digital Subscription
$4.99/week*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*Billed as $19.95 plus GST every four weeks. Cancel any time.
To continue reading, please subscribe:
Add Free Press access to your Brandon Sun subscription for only an additional
$1 for the first 4 weeks*
*Your next subscription payment will increase by $1.00 and you will be charged $16.99 plus GST for four weeks. After four weeks, your payment will increase to $23.99 plus GST every four weeks.
Read unlimited articles for free today:
or
Already have an account? Log in here »
Hey there, time traveller!
This article was published 02/11/2022 (1240 days ago), so information in it may no longer be current.
Visit booth 2228 to experience the interactive display featuring breakthroughs from world-renowned microscopy researchers
WHITE PLAINS, N.Y. , Nov. 2, 2022 /CNW/ — The newly announced
An example of neuroscience specific research presented on the interactive display at the ZEISS booth comes from
In addition to the interactive wall, booth visitors are invited to join three in-booth customer presentations, with topics from “Multicolor confocal imaging through implanted GRIN lenses” delivered by Nicolai T. Urban, Ph.D., Head of Light Microscopy, Max Planck Florida Institute for Neuroscience, to “Reaching the Brain: Developing Novel Genome Engineering Delivery Systems in vivo” delivered by Kyle Fink, Ph.D., Assistant Professor, University of California, Davis Medical Center, and also featured is “AT the Visual Cortex: Mapping Synapses with Correlative Array Tomography” delivered by Jenna Schardt, Research Associate III, Allen Institute for Brain Science. These plus two additional presentations from ZEISS can be found here:
ZEISS is proud to be a partner in helping customers find their next breakthrough and is supporting them with these new innovations. To learn more about ZEISS at SfN Neuroscience 2022 and to book an in-booth live microscopy workflow session, please visit:
ZEISS is an internationally leading technology enterprise operating in the fields of optics and optoelectronics. In the previous fiscal year, the ZEISS Group generated annual revenue totaling 7.5 billion euros in its four segments Semiconductor Manufacturing Technology, Industrial Quality & Research, Medical Technology and Consumer Markets (status: 30 September 2021).
For its customers, ZEISS develops, produces and distributes highly innovative solutions for industrial metrology and quality assurance, microscopy solutions for the life sciences and materials research, and medical technology solutions for diagnostics and treatment in ophthalmology and microsurgery. The name ZEISS is also synonymous with the world’s leading lithography optics, which are used by the chip industry to manufacture semiconductor components. There is global demand for trendsetting ZEISS brand products such as eyeglass lenses, camera lenses and binoculars.
With a portfolio aligned with future growth areas like digitalization, healthcare and Smart Production and a strong brand, ZEISS is shaping the future of technology and constantly advancing the world of optics and related fields with its solutions. The company’s significant, sustainable investments in research and development lay the foundation for the success and continued expansion of ZEISS’ technology and market leadership. ZEISS invests 13 percent of its revenue in research and development – this high level of expenditure has a long tradition at ZEISS and is also an investment in the future.
With around 37,000 employees, ZEISS is active globally in almost 50 countries with around 30 production sites, 60 sales and service companies and 27 research and development facilities (status: 31 March 2022). Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany. The Carl Zeiss Foundation, one of the largest foundations in Germany committed to the promotion of science, is the sole owner of the holding company, Carl Zeiss AG.
Further information at www.zeiss.com
ZEISS Research Microscopy Solutions is the world’s only one-stop manufacturer of light, electron, X-ray and ion microscope systems and offers solutions for correlative microscopy. The portfolio comprises of products and services for life sciences, materials and industrial research, as well as education and clinical practice. The unit is headquartered in Jena. Additional production and development sites are located in Oberkochen and Munich, as well as in Cambourne (UK) and Dublin (USA). ZEISS Research Microscopy Solutions is part of the Industrial Quality & Research segment.
SOURCE ZEISS Research Microscopy Solutions
NEWS RELEASE TRANSMITTED BY Canada Newswire Releases